Keyword: "EGFR"

The Da Nang Oncology Hospital has successfully treated a patient with non-small cell lung cancer (NSCLC) carrying both EGFR and ALK gene mutations simultaneously – an exceptionally rare condition in both medical literature and clinical practice.

The Da Nang’s Oncology Hospital, in cooperation with the biopharmaceutical firm AstraZeneca, has launched its first-ever Epidermal growth factor receptor (EGFR) mutation testing programme.